Acadian Asset Management LLC Sutro Biopharma, Inc. Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 1,609,874 shares of STRO stock, worth $5.55 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,609,874

Previous 1,574,958 2.22%

Holding current value

$5.55 Million

Previous $4.61 Million 20.7%

% of portfolio

0.02%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$2.88 - $5.01 $100,558 - $174,929	34,916 Added 2.22%	1,609,874 $5.57 Million
Q2 2024 Aug 06, 2024	BUY	$2.92 - $5.33 $1.08 Million - $1.98 Million	370,705 Added 30.78%	1,574,958 $4.61 Million
Q1 2024 May 10, 2024	BUY	$3.27 - $5.65 $919,602 - $1.59 Million	281,224 Added 30.47%	1,204,253 $6.8 Million
Q4 2023 Feb 13, 2024	BUY	$2.07 - $4.54 $308,765 - $677,195	149,162 Added 19.27%	923,029 $3.96 Million
Q3 2023 Nov 13, 2023	BUY	$3.29 - $4.9 $392,822 - $585,055	119,399 Added 18.24%	773,867 $2.68 Million
Q2 2023 Aug 07, 2023	SELL	$4.25 - $5.88 $139,259 - $192,669	-32,767 Reduced 4.77%	654,468 $3.04 Million
Q1 2023 May 11, 2023	BUY	$4.48 - $8.45 $561,823 - $1.06 Million	125,407 Added 22.32%	687,235 $3.17 Million
Q4 2022 Feb 14, 2023	SELL	$5.41 - $8.08 $378,548 - $565,373	-69,972 Reduced 11.08%	561,828 $4.54 Million
Q3 2022 Nov 14, 2022	SELL	$5.17 - $7.11 $154,143 - $211,984	-29,815 Reduced 4.51%	631,800 $3.5 Million
Q2 2022 Aug 09, 2022	BUY	$3.41 - $8.95 $1.44 Million - $3.79 Million	423,458 Added 177.81%	661,615 $3.45 Million
Q1 2022 May 12, 2022	BUY	$7.78 - $15.31 $734,735 - $1.45 Million	94,439 Added 65.71%	238,157 $1.96 Million
Q4 2021 Feb 10, 2022	SELL	$14.25 - $23.53 $549,622 - $907,552	-38,570 Reduced 21.16%	143,718 $2.14 Million
Q3 2021 Nov 12, 2021	SELL	$16.88 - $22.38 $678,255 - $899,250	-40,181 Reduced 18.06%	182,288 $3.44 Million
Q2 2021 Aug 11, 2021	SELL	$18.03 - $23.82 $269,079 - $355,489	-14,924 Reduced 6.29%	222,469 $4.14 Million
Q1 2021 May 11, 2021	BUY	$20.29 - $27.54 $2.38 Million - $3.23 Million	117,230 Added 97.56%	237,393 $5.4 Million
Q4 2020 Feb 11, 2021	SELL	$10.16 - $23.98 $68,549 - $161,793	-6,747 Reduced 5.32%	120,163 $2.61 Million
Q3 2020 Nov 09, 2020	BUY	$7.44 - $13.15 $248,079 - $438,473	33,344 Added 35.64%	126,910 $1.28 Million
Q2 2020 Aug 12, 2020	BUY	$7.24 - $11.05 $33,448 - $51,051	4,620 Added 5.19%	93,566 $726,000
Q1 2020 May 11, 2020	BUY	$6.19 - $12.16 $269,258 - $528,947	43,499 Added 95.71%	88,946 $908,000
Q4 2019 Feb 06, 2020	BUY	$8.15 - $11.39 $120,098 - $167,843	14,736 Added 47.98%	45,447 $501,000
Q3 2019 Nov 07, 2019	BUY	$7.91 - $11.76 $171,275 - $254,639	21,653 Added 239.05%	30,711 $279,000
Q2 2019 Aug 08, 2019	BUY	$9.69 - $12.23 $81,783 - $103,221	8,440 Added 1365.7%	9,058 $103,000
Q1 2019 May 09, 2019	BUY	$8.8 - $11.87 $5,438 - $7,335	618 New	618 $7,000

Others Institutions Holding STRO

# of Institutions

135

Shares Held

62.1M

Call Options Held

77.1K

Put Options Held

31.4K

View Full List

About SUTRO BIOPHARMA, INC.

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $180M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

More about STRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Sutro Biopharma, Inc. Transaction History